Hospital Corporation of America (HCA) Awards National Vendor Contract to SpineGuard
PARIS & SAN FRANCISCO–(BUSINESS WIRE)–SpineGuard (FR0011464452 – ALSGD), an innovative company that develops and markets disposable medical devices designed to make spine surgery safer, today announced that it has been awarded a national vendor contract with the HCA network of hospital systems. The HCA network includes over 167 hospitals and 113 free-standing surgery centers in the United States, held under the HealthTrust Purchasing Group organization.
HealthTrust is committed to quality of care and patient safety, strengthening provider performance and clinical excellence. HealthTrust contracts with the best suppliers in the healthcare industry to support its commitment in all its member facilities. HealthTrust Purchasing Group negotiates contracts only with companies that supply products of the highest quality.
Patrick Dyar, Vice President of US Sales for SpineGuard, said: “SpineGuard fully embraces its mission to provide the tools for making spine surgery safer for the surgeon, the hospital staff, and most importantly the patient. The vendor partnership with HCA to provide the PediGuard® devices with DSG™ Technology supports the alignment of SpineGuard’s mission with HealthTrust’s dedication to provide quality patient care.”
Previous press releases:
SpineGuard expands Senior Management Team, Steve McAdoo VP Business Development, on January 25, 2016
SpineGuard reports 2015 revenue growth of 43% to € 6.3M, on January 14, 2016.
SpineGuard secures € 7.7M debt financing with Bpifrance and IPF Partners, on January 11, 2016.
CE mark and world’s first spinal fusion surgery performed with single-step insertion of DSG™ Technology enabled screws, on January 5, 2016.
Next financial press release: 2015 annual results, on March 23, 2016.
About SpineGuard®
Co-founded in 2009 in France and the USA by Pierre Jérôme and Stéphane Bette, SpineGuard’s mission is to make spine surgery safer. Its primary objective is to establish its proprietary DSG™ (Dynamic Surgical Guidance) technology as the global standard of surgical care, initially for safer screw placement in spine surgery and then in other surgeries. PediGuard®, the first device designed using DSG was co-invented by Maurice Bourlion, Ph.D., Ciaran Bolger, M.D., Ph.D., and Alain Vanquaethem, Biomedical Engineer. It is the world’s first and only handheld device capable of alerting surgeons to potential pedicular or vertebral breaches. Over 40,000 surgical procedures have been performed worldwide with PediGuard. Numerous studies published in peer-reviewed medical and scientific journals have demonstrated the multiple benefits that PediGuard delivers to patients, surgical staff and hospitals. In 2015, SpineGuard started to expand the applications of DSG into pedicle screws through partnerships with innovative surgical companies in France and the US. SpineGuard has offices in San Francisco and Paris. For further information, visit www.spineguard.com.
Disclaimer
The SpineGuard securities may not be offered or sold in the United States as they have not been and will not be registered under the Securities Act or any United States state securities laws, and SpineGuard does not intend to make a public offer of its securities in the United States. This is an announcement and not a prospectus, and the information contained herein does and shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of the securities referred to herein in the United States in which such offer, solicitation or sale would be unlawful prior to registration or exemption from registration.
Contacts
SpineGuard
Pierre Jérôme, +33 (0)1 45 18 45 19
Chief Executive Officer
p.jerome@spineguard.com
or
Manuel Lanfossi
Chief Financial Officer
m.lanfossi@spineguard.com
or
Europe / NewCap
Investor Relations & Financial Communication
Florent Alba / Pierre Laurent, +33 (0)1 44 71 94 94
spineguard@newcap.fr
or
US
Ronald Trahan Associates Inc.
Ronald Trahan, APR, +1-508-359-4005, x108